MedWatch

Global supply issues have ALK thinking creatively

The Covid-19 pandemic has seriously unbalanced the global supply chains, causing increasing freight rates and instability. Thinking on its feet, ALK needed to come up with alternative solutions to keep production running. "It might not all look pretty, but we are managing."

Photo: Gregers Tycho/Ritzau/Ritzau Scanpix

Massive bottlenecking and tough competition to acquire needed components, like filters and sterile bags, have forced the allergy firm ALK to think of creative solutions to avoid production of its vaccines slowing down or coming to a halt.

The Danish firm has plants in Denmark, Spain, France and the US, and in all locations, the allergy group uses several products and raw materials to produce its allergy vaccines, which target against common allergens including grass, dust and pollen.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs